supp.fit

Ashwagandha: study protocols

42 study groups say how much Ashwagandha participants took a day. These are the doses the studies gave. They are not a recommendation.

Ashwagandha: what the research found →

Dose per serving from products

1,468 products in our catalogue print how much Ashwagandha a serving holds.

Most common: 100 mg to 250 mg, 26% of 1,468 products.

Dose per servingProducts
25 mg or less
73
25 mg to 50 mg
149
50 mg to 100 mg
372
100 mg to 250 mg
383
250 mg to 500 mg
312
500 mg to 1 g
96
1 g to 2.5 g
60
over 2.5 g
23

Dose per serving from research

42 study groups in 36 studies say how much Ashwagandha participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g, 48% of 42 study groups.

Daily doseStudy groups
100 mg to 250 mg
9
250 mg to 500 mg
11
500 mg to 1 g
20
over 1 g
2

Commonly used together

5 of 42 study groups took Ashwagandha with something else, but nothing that 3 or more different studies gave.

42 study groups

Study
Withania somnifera as a safer option to hydroxychloroquine in the chemoprophylaxis of COVID-19: Results of interim analysis
2021 · Ashwagandha · Health care workers engaged in combatting COVID-19; adults, with mean age 38.38 years in the interim group
500 mg16 weeks80
Safety and Efficacy of Ashwagandha Root Extract on Cognition, Energy and Mood Problems in Adults: Prospective, Randomized, Placebo-Controlled Study
2026 · Ashwagandha root extract (ARE) · Healthy adults aged 30–75 years with self-reported cognitive and energy problems
600 mg8 weeks60
Efficacy and safety of Ashwagandha (Withania somnifera) root extract on stress and weight management in adults: a prospective, randomized, double-blind, placebo-controlled study
2025 · ARE group · Men and women aged 19–65 years with overweight or obesity (BMI 25.0–39.9 kg/m²)
600 mg180 days50
Effects of Ashwagandha ( Withania somnifera) standardized root extract on physical endurance and VO (2max) in healthy adults performing resistance training: An eight-week, prospective, randomized, double-blind, placebo-controlled study
2023 · AG (Ashwagandha) group · Healthy, physically active adults aged 18–45 years, men and women, undertaking regular resistance training
600 mg8 weeks40
Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study
2018 · WSE · Patients with schizophrenia or schizoaffective disorder experiencing an exacerbation of symptoms
1 g12 weeks33
Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial
2024 · WS500 group · Adults aged 18–60 with chronic-stress-related anxiety, depression, and/or sleep disturbance for more than 3 months and elevated Perceived Stress Scale scores
500 mg8 weeks31
Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Improving Sexual Function in Women: A Pilot Study
2015 · HCARE-treated group (Group A) · Women aged 21–50 with female sexual dysfunction, including hypoactive sexual desire disorder, female sexual arousal disorder, female orgasmic disorder, or combined genital and subjective arousal disorder
600 mg8 weeks25
Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial
2015 · Ashwagandha group · Healthy men aged 18–50 undergoing resistance training
600 mg8 weeks25
A double-blind, randomized, placebo-controlled trial on the effect of Ashwagandha (Withania somnifera dunal.) root extract in improving cardiorespiratory endurance and recovery in healthy athletic adults
2021 · Ashwagandha group · Healthy athletic adults
600 mg8 weeks25
Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder
2013 · WSE · Euthymic adults with DSM-IV bipolar disorder receiving maintenance medication
500 mg8 weeks24
Assessment of the Efficacy of Withania somnifera Root Extract in Patients with Generalized Anxiety Disorder: A Randomized Double-blind Placebo- Controlled Trial
2021 · W. somnifera extract group · Patients with confirmed generalized anxiety disorder receiving selective serotonin reuptake inhibitors
1 g6 weeks22
Effects of Root Extract of Ashwagandha (Withania somnifera) on Perception of Recovery and Muscle Strength in Female Athletes
2025 · ASH · Female professional footballers aged 18–36, healthy and free of disease
600 mg4 weeks15
Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract: A Double-Blind, Randomized, Placebo-Controlled Trial
2017 · Ashwagandha · Adults under chronic stress
600 mg8 weeks—
Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions
2017 · Ashwagandha-root extract group · Adults with mild cognitive impairment; age and sex not specified
600 mg8 weeks—
Effects of an Aqueous Extract of Withania somnifera on Strength Training Adaptations and Recovery: The STAR Trial
2018 · Ashwagandha (S500) group · Apparently healthy, recreationally active men aged 18–45 years
500 mg12 weeks—
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera) in Aging, Overweight Males
2019 · Ashwagandha period · Healthy overweight males aged 40–70 years with mild-to-moderate self-reported fatigue or reduced vitality
600 mg8 weeks—
Effect of an ashwagandha (Withania Somnifera) root extract on climacteric symptoms in women during perimenopause: A randomized, double-blind, placebo-controlled study
2021 · Ashwagandha root extract · Women with climacteric symptoms during perimenopause
600 mg8 weeks—
The Perceived Impact of Ashwagandha on Stress, Sleep Quality, Energy, and Mental Clarity for College Students: Qualitative Analysis of a Double-Blind Randomized Control Trial
2022 · intervention group · College students aged 18–50 years
700 mg30 days—
The Impact of Ashwagandha on Stress, Sleep Quality, and Food Cravings in College Students: Quantitative Analysis of a Double-Blind Randomized Control Trial
2022 · Ashwagandha group · Healthy college students; age and sex not specified
700 mg30 days—
Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin®) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial
2023 · ashwagandha · Men and women aged 40–75 years with BMI 25–35, low energy, fatigue, and moderate-to-high stress
400 mg12 weeks60
Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial
2024 · WS250 group · Adults aged 18–60 with chronic-stress-related anxiety, depression, and/or sleep disturbance for more than 3 months and elevated Perceived Stress Scale scores
250 mg8 weeks33
Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial
2023 · Ayurveda group (AG) · People with mild or moderate COVID-19; age and sex not reported
500 mg15 days25
Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study
2025 · Somin-On™ group · Adults with mild cognitive impairment (MCI); age and sex not specified
250 mg60 days20
A New Ashwagandha Formulation (Zenroot™) Alleviates Stress and Anxiety Symptoms While Improving Mood and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Clinical Study
2025 · ZEN (Zenroot™) group · Adults aged 18–55, male and female, with non-chronic mild-to-moderate stress
125 mg12 weeks45
Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial
2024 · WS125 group · Adults aged 18–60 with chronic-stress-related anxiety, depression, and/or sleep disturbance for more than 3 months and elevated Perceived Stress Scale scores
125 mg8 weeks34
An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study
2019 · ashwagandha group · Healthy male and female adults aged 18–65 years with mild stress (HAM-A score 6–17)
240 mg60 days30
Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood
2024 · ashwagandha (ASH) group · Healthy men and women aged 18–49 years (study eligibility 18–60), without diagnosed cognitive deficits or the listed exclusions
225 mg30 days30
Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: A randomized double-blind placebo-controlled trial
2016 · treatment group · Adults with confirmed obsessive-compulsive disorder receiving SSRIs; age and sex not stated
120 mg6 weeks15
A randomized, double blind, placebo controlled study to evaluate the effects of ashwagandha (Withania somnifera) extract on sleep quality in healthy adults
2020 · Ashwagandha group · Healthy adults with high non-restorative sleep measures; age and sex not stated
120 mg6 weeks—
Randomized placebo-controlled pilot clinical trial on the efficacy of ayurvedic treatment regime on COVID-19 positive patients
2021 · Treatment Arm · Patients aged 15–80 with asymptomatic or mild COVID-19, positive by RT-PCR; non-pregnant women, with no stated major comorbidities
1 g7 days45
Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974
2009 · Naturopathic Care (NC) · Adult Canada Post employees with moderate or greater anxiety; women and men, mean age about 52 years
600 mg12 weeks41
A Standardized Withania somnifera (Linn.) Root Extract with Piperine Alleviates the Symptoms of Anxiety and Depression by Increasing Serotonin Levels: A Double-Blind, Randomized, Placebo-Controlled Study
2024 · ARE · Individuals with mild to moderate depression and anxiety
500 mg90 days34
A standardized Ashwagandha root extract alleviates stress, anxiety, and improves quality of life in healthy adults by modulating stress hormones: Results from a randomized, double-blind, placebo-controlled study
2023 · ARE (Ashwagandha root extract) · Adults aged 21–54 years with mild-to-moderate stress and anxiety, without chronic disease
500 mg60 days27
Superior Bioavailability of a Novel 1.5% Ashwagandha Formulation (Zenroot™): A Randomized, Double-Blind, Single-Dose, Comparative, Oral Bioavailability Study in Healthy Adults
2025 · ASH 5 (Ashwagandha 5%) · Healthy adults aged 18–55 years, male and female
600 mg1 day18
Superior Bioavailability of a Novel 1.5% Ashwagandha Formulation (Zenroot™): A Randomized, Double-Blind, Single-Dose, Comparative, Oral Bioavailability Study in Healthy Adults
2025 · ASH 10 (Ashwagandha 10%) · Healthy adults aged 18–55 years, male and female
500 mg1 day14
Ashwagandha Root Extract Stabilises Physiological Stress Responses in Male and Female Team Sports Athletes During Pre-Season Training
2026 · Ashwagandha (ASH) group · Healthy male and female semi-professional team-sport athletes aged 18–35 years
600 mg6 weeks28
Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial
2018 · Ashwagandha treatment group · Adults aged 18–50 with subclinical hypothyroidism and elevated serum TSH levels (4.5–10 μIU/L)
600 mg8 weeks25
Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin®) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial
2023 · ashwagandha · Men aged 40–75 years with BMI 25–35, low energy, fatigue, and moderate-to-high stress
400 mg12 weeks28
Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin®) in adults experiencing high stress and fatigue in a randomized, double-blind, placebo-controlled trial
2023 · ashwagandha · Women aged 40–75 years with BMI 25–35, low energy, fatigue, and moderate-to-high stress
400 mg12 weeks24
Effects of Withania somnifera in patients of schizophrenia: a randomized, double blind, placebo controlled pilot trial study
2013 · Withania somnifera extract (WSE) · Adults with schizophrenia receiving second-generation antipsychotics for at least 6 months and metabolic syndrome criteria
1.2 g30 days15
Superior Bioavailability of a Novel 1.5% Ashwagandha Formulation (Zenroot™): A Randomized, Double-Blind, Single-Dose, Comparative, Oral Bioavailability Study in Healthy Adults
2025 · ZEN 1.5 (Ashwagandha 1.5%) · Healthy adults aged 18–55 years, male and female
125 mg1 day18
Comparative evaluation of the effects of Withania somnifera with pentoxifylline on the sperm parameters in idiopathic male infertility: A triple-blind randomised clinical trial
2018 · W. somnifera group · Male patients with idiopathic infertility; age range not reported
5 g90 days—